Learn with Anil · UPSC Civil Services PYQsMains PYQs →Subscribe ₹149
INS Vikrant and INS Vikramaditya sailing with their carrier battle group

Photo: INS Vikrant and INS Vikramaditya, Indian Navy, GODL-India

UPSC Civil Services (Main) 2021 · GS Paper III

UPSC Mains 2021 GS 3 · Q15: model answer

General Studies Paper III: Technology, Economic Development, Bio-diversity, Environment, Security and Disaster Management · Science and Technology.

Q1515 marks250 words2021 · GS Paper III

What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of the society?

Syllabus: Science and Technology · Biotechnology and health technology

Model answer · free

Applied biotechnologyGenome editingAffordable healthcareBioeconomy

Applied biotechnology uses living organisms, cells and their molecules to make products for health, agriculture, industry and the environment. India's research system, led by the Department of Biotechnology (1986), ICAR, ICMR and CSIR, with start-ups supported by BIRAC, has helped its bioeconomy grow to about US$195 billion in 2025. The BioE3 policy (2024) now aims to build high-performance biomanufacturing.

1. Research and development achievements

  • Vaccines: India makes nearly 60% of the world's vaccines; indigenous products include the rotavirus vaccine Rotavac, Covaxin, ZyCoV-D (2021, the world's first DNA vaccine for humans) and the HPV vaccine CERVAVAC.
  • Advanced therapies: NexCAR19 (2023), India's own CAR-T cell therapy for blood cancers, and BIRSA 101 (2025), a CRISPR-based therapy for sickle cell disease built on CSIR-IGIB's enFnCas9.
  • Diagnostics and genomics: affordable molecular tests such as TrueNat for TB and the CRISPR-based FELUDA test for COVID-19; the Genome India project has sequenced 10,000 genomes for precision medicine.
  • Agriculture: Bt cotton (2002); marker-assisted Improved Samba Mahsuri rice, resistant to bacterial blight; the world's first genome-edited rice varieties, DRR Dhan 100 (Kamala) and Pusa DST Rice 1 (May 2025); biofortified crops; and tissue-cultured planting material.
  • Industry and environment: enzymes, biofertilisers and biopesticides, second-generation ethanol, bioremediation of oil spills and polluted sites, and bio-toilets.
  • Animal health: indigenous vaccines such as Lumpi-ProVacInd (2022) against lumpy skin disease in cattle.
SectorAchievementHow it helps the poor
HealthLow-cost vaccines, NexCAR19, BIRSA 101Affordable prevention and cures
DiagnosticsTrueNat, FELUDAQuick tests close to home
AgricultureStress-tolerant and genome-edited riceStable yields for small farmers
NutritionBiofortified crops, fortified riceFights hidden hunger
LivestockLumpy skin disease vaccineProtects the poor's cattle
EnvironmentBio-toilets, bioremediationSanitation and cleaner water
Biotech achievements and the poor

2. How these achievements help the poorer sections

  • Affordable healthcare: domestic vaccines reach every child free under the Universal Immunisation Programme; NexCAR19 costs a fraction of imported CAR-T therapies; and gene therapy for sickle cell disease targets an illness common among tribal communities, also addressed by the National Sickle Cell Anaemia Elimination Mission (2023).
  • Higher and stable farm incomes: flood-, drought- and salt-tolerant varieties reduce crop losses for small farmers in rainfed and coastal areas; Kamala rice yields about 19% more and matures 15–20 days earlier.
  • Fighting hidden hunger: zinc- and iron-rich biofortified varieties and fortified rice in the PDS address anaemia and micronutrient deficiency.
  • Livelihoods: livestock vaccines protect the main asset of landless and women farmers, while bio-input units, biogas plants and biomanufacturing create rural jobs.
  • Cleaner surroundings: bio-toilets and bioremediation improve sanitation and water quality in poor neighbourhoods.
Public research (DBT, ICAR, ICMR, CSIR)
Indigenous, low-cost products
Public delivery: immunisation, PDS, seed systems
Lower costs, fewer losses, better health
Higher incomes and well-being
From laboratory to the poor

3. Challenges

  • Access and cost: advanced therapies remain expensive and concentrated in big hospitals.
  • Biosafety and trust: pink bollworm now resists Bt cotton, and GM mustard is on hold after the Supreme Court's split verdict (2024).
  • Research gaps: low R&D spending, weak lab-to-market translation and intellectual property barriers.

Biotechnology can be a pro-poor technology when public research, affordable pricing and strong biosafety go together. The BioE3 policy and public-private partnerships must keep equity at their centre.

Every model answer here is free

The ₹149 All-in-One Pass opens the rest of the site for 12 months: UPSC Prelims GS Paper I and CSAT with explanations, practice quizzes and timed tests, UPSC CAPF and EPFO, the previous papers of every APPSC, TSPSC, police and SSC exam, every mock test series and the study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149